Abstract
Bacteremia is a significant complication of allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to study bacteremia occurring during early post-transplant period at Bone Marrow Transplantation Unit of Ain Shams University regarding its risk factors and impact on survival. Patients performing allogeneic HSCT were followed up for occurrence of bacteremia. Survival status was assessed at 180 days post-transplant. Bacteremia occurred in 53.3 % of patients. On univariate analysis, CD34 +ve cell dose (P = 0.004), duration of neutropenia (P = 0.018), time interval between day of stem cell infusion and day of neutrophil engraftment (P = 0.043) and > 1 apheresis days (P = 0.040) were associated with higher rates of bacteremia. On multivariate analysis, CD34 +ve cell dose (P = 0.002) and apheresis day number (P = 0.038) remained significant. There was significant difference between patients who developed bacteremia and those who did not regarding overall survival (OS) (P = 0.042). Patients developing bacteremia caused by Gram negative bacteria (GNB) had lower OS than Gram positive bacteria (GPB) (P < 0.001). In conclusion, stem cell dose and apheresis day number influence bacteremia risk. Also, Gram negative bacteremia has negative impact on allogeneic transplant recipient survival rates.
Similar content being viewed by others
References
Kedia S, Acharya PS, Mohammad F, Nguyen H, Asti D, Mehta S, Pant M, Mobarakai N (2013) Infectious complications of hematopoietic stem cell transplantation. J Stem Cell Res Ther S3:002
Collin BA, Leather HL, Wingard JR, Ramphal R (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Inf Dis 33:947–953
Worth LJ, Slavin MA (2009) Bloodstream infections in haematol-ogy: risks and new challenges for prevention. Blood Rev 23:113–122
Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martínez JA, Carreras E, Mensa J (2005) Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 84:40–46
Guthrie KA, Yong M, Frieze D, Corey L, Fredricks DN (2009) The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transpl 45:675–681
Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C (2009) Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transpl 15:47–53
Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN, Kiehn TE, Pamer E, Papanicolaou GA (2005) Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 7:11–17
Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR (2007) Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transpl 40:63–70
Maschmeyer G, Ljungman P (2011) Infections in hematopoietic stem cell transplant recipients. In: Safdar A (ed) Principles and practice of cancer infectious diseases, current clinical oncology. Springer Science + Business Media, New York, pp 17–25
Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the current-ly isolated pathogens. Clin Infect Dis 39(Suppl 1):S25–S31
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin In-fect Dis 36:1103–1110
Jugo J, Kennedy R, Crowe MJ, Lamrock G, McClurg RB, Rooney PJ, Morris TC, Johnston PG (2002) Trends in bacteraemia on the haematology and oncology units of a UK tertiary re-ferral hospital. J Hosp Infect 50:48–55
Gonçalves TL, Benvegnú DM, Bonfanti G (2009) Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. Oxid Med Cell Longev 2:82–87
Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100:228–237
Ninin E, Milpied N, Moreau P, Andre-Richet B, Morineau N, Mahe B, Vigier M, Imbert BM, Morin O, Harousseau JL, Richet H (2001) Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33:41–47
Sparrelid E, Hagglund H, Remberger M, Ringden O, Lonnqvist B, Ljungman P, Andersson J (1998) Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transpl 22:795–800
Therriault BL, Wilson JW, Barreto JN, Estes LL (2010) Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline. Mayo Clin Proc 85:711–718
Busca A, Cavecchia I, Locatelli F, D’Ardia S, De Rosa FG, Marmont F, Ciccone G, Baldi I, Serra R, Gaido E, Falda M (2012) Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis 14:40–48
Rosa RG, dos Santos RP, Goldani LZ (2014) Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study. Can J Infect Dis Med Microbiol 25:e14–e17
Frère P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y (2004) Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transpl 33:745–749
Ghazal SS, Stevens MP, Bearman GM, Edmond MB (2014) Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation. Antimicrob Resist Infect Control 3:20
Oliveira AL, de Souza M, Carvalho-Dias VMH, Ruiz MA, Silla L, Yurie Tanaka P, Simoes BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M (2007) Epidemiology of bacteremia and factors associated with multi-drug resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transpl 39:775–781
Mendes ET, Dulley F, Basso M, Batista MV, Coracin F, Guimaraes T, Shikanai-Yasuda MA, Levin AS, Costa SF (2012) Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. Int J Infect Dis 16:e424–e428
Cappellano P, Viscoli C, Bruzzi P, Van Lint MT, Pereira CAP, Bacigalupo A (2007) Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion. New Microb 30:89–99
Kwon JC, Kim SH, Choi JK, Cho SY, Park YJ, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH (2013) Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center. Infect Chemother 45:51–61
Bittencourt H, Rocha V, Chevret S, Socie G, Esperou H, Devergie A, Dal Cortivo L, Marolleau J, Garnier F, Ribaud P, Gluckman E (2002) Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 99:2726–2733
Rajasekar R, Mathews V, Lakshmi KM, George B, Viswabandya A, Chandy M, Srivastava A (2009) Cellular Immune reconstitution and its impact on clinical outcome in children with β thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant. Biol Blood Marrow Transpl 15:597–609
Horwitz ME, Sullivan KM (2006) Chronic graft-versus-host disease. Blood Rev 20:15–27
Almeida ID, Schmalfuss T, Rohsig LM, Goldani LZ (2012) Autologous transplant: microbial contamination of hematopoietic stem cell products. Braz J Infect Dis 16:345–350
Majado MJ, Garcia-Hernandez A, Morales A, Gonzalez C, Martinez-Sanchez V, Menasalvas A, Rosique P, Rubio A, Sanz-Imedio E (2007) Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant. Bone Marrow Transpl 39:121–125
Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H (2010) Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 14:R27
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Standards
All procedures performed were in accordance with the ethical standards of the research committee of Faculty of Medicine of Ain Shams University and with the 1964 Helsinki declaration and its later amendments.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
El-Ghammaz, A.M.S. Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell Transplantation Period: A Single Center Experience. Indian J Hematol Blood Transfus 33, 200–206 (2017). https://doi.org/10.1007/s12288-016-0703-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0703-x